Liver Disease and Treatment Needs of Asymptomatic Persons Living With Hepatitis B in Senegal.

Senegal hepatitis B liver fibrosis

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 08 08 2022
accepted: 26 10 2022
entrez: 16 11 2022
pubmed: 17 11 2022
medline: 17 11 2022
Statut: epublish

Résumé

The prevalence of active hepatitis B among asymptomatic persons remains unclear in Africa. Of 1206 newly diagnosed persons in Senegal, 12.3% had significant fibrosis and 31.3% had hepatitis B virus (HBV) DNA levels >2000 IU/mL. Overall, 128 (12.9%) were eligible for antiviral therapy. Generalized HBV screening allowed the identification of a large population requiring HBV care.

Identifiants

pubmed: 36381617
doi: 10.1093/ofid/ofac558
pii: ofac558
pmc: PMC9664968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofac558

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Clin Infect Dis. 2022 May 20;:
pubmed: 35594550
Gastroenterology. 2006 Mar;130(3):678-86
pubmed: 16530509
Liver Int. 2021 Apr;41(4):710-719
pubmed: 33220137
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):106-119
pubmed: 33197397
J Hepatol. 2019 Jun;70(6):1065-1071
pubmed: 30929749
J Hepatol. 2017 Aug;67(2):370-398
pubmed: 28427875
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):146-147
pubmed: 33323992
Lancet Glob Health. 2016 Aug;4(8):e559-67
pubmed: 27443781
PLoS Med. 2020 Apr 21;17(4):e1003068
pubmed: 32315297
PLoS One. 2012;7(9):e44930
pubmed: 23049764
J Viral Hepat. 2022 Jan;29(1):60-68
pubmed: 34610183
JAMA. 2006 Jan 4;295(1):65-73
pubmed: 16391218

Auteurs

Adrià Ramírez Mena (A)

Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal.
Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Graduate School of Health Sciences, University of Bern, Bern, Switzerland.

Mame Aissé Thioubou (MA)

Department of Gastroenterology, Hôpital Universitaire de la Paix, Ziguinchor, Senegal.

Kalilou Diallo (K)

Department of Infectious Diseases, Hôpital Universitaire de la Paix, Ziguinchor, Senegal.

Judicaël Tine (J)

Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal.

Ndeye Fatou Ngom (NF)

Centre de Traitement Ambulatoire, Fann University Hospital, Dakar, Senegal.

Louise Fortes (L)

Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal.

Kiné Ndiaye (K)

Centre de Traitement Ambulatoire, Fann University Hospital, Dakar, Senegal.

Jean-Claude Karasi (JC)

Department of Infectious Diseases, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg.

Carole Seguin-Devaux (C)

Department of Infection and Immunity, Luxembourg Health Institute, Luxembourg, Luxembourg.

Henri Goedertz (H)

Department of Infectious Diseases, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg.

Daouda Diouf (D)

ENDA (Environnement, Développement et Action) Santé, Dakar, Senegal.

Moussa Seydi (M)

Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal.

Benjamin Amaye Sambou (BA)

ENDA (Environnement, Développement et Action) Santé, Dakar, Senegal.

Vic Arendt (V)

Department of Infectious Diseases, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg.

Gilles Wandeler (G)

Department of Infectious and Tropical Diseases, Fann University Hospital, Dakar, Senegal.
Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Noël Magloire Manga (NM)

Department of Infectious Diseases, Hôpital Universitaire de la Paix, Ziguinchor, Senegal.

Classifications MeSH